The quest for the adult cardiac stem cell

Circulation Journal

Volumn 79, Issue 7, 2015, Pages 1422-1430

  Noseda, Michela ^a   Abreu Paiva, Marta ^a   Schneider, Michael D ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cardiac regeneration; Heart repair; Platelet derived growth factor receptor ; Stem cells

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ADULT STEM CELL; ANIMAL; ANIMAL MODEL; BIOLOGICAL MODEL; BIOLOGICAL THERAPY; CARDIAC MYOBLAST; CELL DIFFERENTIATION; CELL LINEAGE; CYTOLOGY; GENE EXPRESSION PROFILING; HEART; HUMAN; MOUSE; PHYSIOLOGY; REGENERATION; TRANSPLANTATION; ZEBRA FISH;

ADULT; ADULT STEM CELLS; ANIMALS; BIOMARKERS; CELL DIFFERENTIATION; CELL LINEAGE; CELL- AND TISSUE-BASED THERAPY; GENE EXPRESSION PROFILING; HEART; HUMANS; MICE; MODELS, ANIMAL; MODELS, CARDIOVASCULAR; MYOBLASTS, CARDIAC; REGENERATION; ZEBRAFISH;

EID: 84934268195     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-15-0557     Document Type: Review

References (96)

1. Mercola M, Ruiz-Lozano P, Schneider MD. Cardiac muscle regeneration: Lessons from development. Genes Dev 2011; 25: 299-309.
2. Lin Z, Pu WT. Strategies for cardiac regeneration and repair. Sci Transl Med 2014; 6: 239rv1.
3. Gerbin KA, Murry CE. The winding road to regenerating the human heart. Cardiovasc Pathol 2015; 24: 133-140.
4. van Berlo JH, Molkentin JD. An emerging consensus on cardiac regeneration. Nat Med 2014; 20: 1386-1393.
5. Chong JJ, Forte E, Harvey RP. Developmental origins and lineage descendants of endogenous adult cardiac progenitor cells. Stem Cell Res 2014; 13: 592-614.
6. Fox IJ, Daley GQ, Goldman SA, Huard J, Kamp TJ, Trucco M. Stem cell therapy: Use of differentiated pluripotent stem cells as replacement therapy for treating disease. Science 2014; 345: 1247391.
7. World Health Organization. Global health estimates: Deaths by cause, age, sex and country, 2000–2012. Geneva: WHO, 2014.
8. Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D’Agostino RB, et al. Long-term trends in the incidence of heart failure after myocardial infarction. Circulation 2008; 118: 2057-2062.
9. Moran AE, Forouzanfar MH, Roth GA, Mensah GA, Ezzati M, Murray CJ, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: The Global Burden of Disease 2010 study. Circulation 2014; 129: 1483-1492.
10. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, et al. The global health and economic burden of hospitalizations for heart failure: Lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63: 1123-1133.
11. Vigen R, Maddox TM, Allen LA. Aging of the United States population: Impact on heart failure. Curr Heart Fail Rep 2012; 9: 369-374.
12. Cano-Martinez A, Vargas-Gonzalez A, Guarner-Lans V, Prado Zayago E, Leon-Oleda M, Nieto-Lima B. Functional and structural regeneration in the axolotl heart (Ambystoma mexicanum) after partial ventricular amputation. Arch Cardiol Mex 2010; 80: 79-86.
13. Forbes SJ, Rosenthal N. Preparing the ground for tissue regeneration: From mechanism to therapy. Nat Med 2014; 20: 857-869.
14. Kikuchi K, Poss KD. Cardiac regenerative capacity and mechanisms. Annu Rev Cell Dev Biol 2012; 28: 719-741.
15. Wang J, Cao J, Dickson AL, Poss KD. Epicardial regeneration is guided by cardiac outflow tract and Hedgehog signalling. Nature 2015 May 4, doi:10.1038/nature14325.
16. Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, et al. Transient regenerative potential of the neonatal mouse heart. Science 2011; 331: 1078-1080.
17. Porrello ER, Olson EN. A neonatal blueprint for cardiac regeneration. Stem Cell Res 2014; 13: 556-570.
18. Aurora AB, Porrello ER, Tan W, Mahmoud AI, Hill JA, Bassel Duby R, et al. Macrophages are required for neonatal heart regeneration. J Clin Invest 2014; 124: 1382-1392.
19. Xin M, Kim Y, Sutherland LB, Murakami M, Qi X, McAnally J, et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc Natl Acad Sci USA 2013; 110: 13839-13844.
20. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98-102.
21. Kajstura J, Rota M, Cappetta D, Ogorek B, Arranto C, Bai Y, et al. Cardiomyogenesis in the aging and failing human heart. Circulation 2012; 126: 1869-1881 (Notice of retraction, Circulation 2014; 129: e1466).
22. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, et al. Mammalian heart renewal by pre-existing cardiomyocytes. Nature 2013; 493: 433-436.
23. Walsh S, Ponten A, Fleischmann BK, Jovinge S. Cardiomyocyte cell cycle control and growth estimation in vivo: An analysis based on cardiomyocyte nuclei. Cardiovasc Res 2010; 86: 365-373.
24. Hesse M, Raulf A, Pilz GA, Haberlandt C, Klein AM, Jabs R, et al. Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle. Nat Commun 2012; 3: 1076.
25. Hsieh PC, Segers VF, Davis ME, MacGillivray C, Gannon J, Molkentin JD, et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 2007; 13: 970-974.
26. Uchida S, De Gaspari P, Kostin S, Jenniches K, Kilic A, Izumiya Y, et al. Sca1-derived cells are a source of myocardial renewal in the murine adult heart. Stem Cell Rep 2013; 1: 397-410.
27. Hsueh YC, Wu JM, Yu CK, Wu KK, Hsieh PC. Prostaglandin E2 promotes post-infarction cardiomyocyte replenishment by endogenous stem cells. EMBO Mol Med 2014; 6: 496-503.
28. + stem/ progenitor cell in adult murine myocardium. Nat Commun 2015; 6: 6930.
29. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, et al. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003; 100: 12313-12318.
30. Holmes C, Stanford WL. Stem cell antigen-1: Expression, function, and enigma (Concise review). Stem Cells 2007; 25: 1339-1347.
31. Matsuura K, Nagai T, Fukushima N, Iwanaga K, Tokunaga M, Shimizu T, et al. Transplantation of cardiac progenitor cells ameliorates cardiac dysfunction after myocardial infarction in mice. J Clin Invest 2009; 119: 2204-2217.
32. + cardiosphere-derived cells are enriched for isl1-expressing cardiac precursors and improve cardiac function after myocardial injury. PLoS One 2012; 7: e30329, doi:10.1371/journal.pone.0030329.
33. Bailey B, Fransioli J, Gude NA, Alvarez R Jr, Zhang X, Gustafsson AB, et al. Sca-1 knockout impairs myocardial and cardiac progenitor cell function. Circ Res 2012; 111: 750-760.
34. Rosenblatt-Velin N, Ogay S, Felley A, Stanford WL, Pedrazzini T. Cardiac dysfunction and impaired compensatory response to pressure overload in mice deficient in stem cell antigen-1. FASEB J 2012; 26: 229-239.
35. Hoch M, Fischer P, Stapel B, Missol-Kolka E, Sekkali B, Scherr M, et al. Erythropoietin preserves the endothelial differentiation poten tial of cardiac progenitor cells and attenuates heart failure during anti-cancer therapies. Cell Stem Cell 2011; 5: 131-143.
36. Linke A, Muller P, Nurzynska D, Casarsa C, Torella D, Nascimbene A, et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function. Proc Natl Acad Sci USA 2005; 102: 8966-8971.
37. Ellison GM, Vicinanza C, Smith AJ, Aquila I, Leone A, Waring CD, et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 2013; 154: 827-842.
38. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797-1806.
39. Matsuzaki Y, Kinjo K, Mulligan RC, Okano H. Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity 2004; 20: 87-93.
40. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 2004; 265: 262-275.
41. + cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005; 97: 52-61.
42. Oyama T, Nagai T, Wada H, Naito AT, Matsuura K, Iwanaga K, et al. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 2007; 176: 329-341.
43. Messina E, De Angelis L, Frati G, Morrone S, Chimenti S, Fiordaliso F, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004; 95: 911-921.
44. Cheng K, Ibrahim A, Hensley MT, Shen D, Sun B, Middleton R, et al. Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction. J Am Heart Assoc 2014; 3: e001260, doi:10.1161/JAHA.114.001260.
45. Chong JJ, Chandrakanthan V, Xaymardan M, Asli NS, Li J, Ahmed I, et al. Adult cardiac-resident MSC-like stem cells with a proepicardial origin. Cell Stem Cell 2011; 9: 527-540.
46. Pelekanos RA, Li J, Gongora M, Chandrakanthan V, Scown J, Suhaimi N, et al. Comprehensive transcriptome and immunophenotype analysis of renal and cardiac MSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities. Stem Cell Res 2012; 8: 58-73.
47. Minasi MG, Riminucci M, De Angelis L, Borello U, Berarducci B, Innocenzi A, et al. The meso-angioblast: A multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 2002; 129: 2773-2783.
48. Galvez BG, Sampaolesi M, Barbuti A, Crespi A, Covarello D, Brunelli S, et al. Cardiac mesoangioblasts are committed, selfrenewable progenitors, associated with small vessels of juvenile mouse ventricle. Cell Death Differ 2008; 15: 1417-1428.
49. Galli D, Innocenzi A, Staszewsky L, Zanetta L, Sampaolesi M, Bai A, et al. Mesoangioblasts, vessel-associated multipotent stem cells, repair the infarcted heart by multiple cellular mechanisms: A comparison with bone marrow progenitors, fibroblasts, and endothelial cells. Arterioscler Thromb Vasc Biol 2005; 25: 692-697.
50. Lamagna C, Bergers G. The bone marrow constitutes a reservoir of pericyte progenitors. J Leukoc Biol 2006; 80: 677-681.
51. Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y, et al. Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 2011; 109: 894-906.
52. Laugwitz KL, Moretti A, Caron L, Nakano A, Chien KR. Islet1 cardiovascular progenitors: A single source for heart lineages? Development 2008; 135: 193-205.
53. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 2004; 432: 466-472.
54. Smart N, Bollini S, Dube KN, Vieira JM, Zhou B, Davidson S, et al. De novo cardiomyocytes from within the activated adult heart after injury. Nature 2011; 474: 640-644.
55. Dey D, Han L, Bauer M, Sanada F, Oikonomopoulos A, Hosoda T, et al. Dissecting the molecular relationship among various cardiogenic progenitor cells. Circ Res 2013; 112: 1253-1262.
56. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science 2006; 313: 1922-1927.
57. Hidaka K, Shirai M, Lee JK, Wakayama T, Kodama I, Schneider MD, et al. The cellular prion protein identifies bipotential cardiomyogenic progenitors. Circ Res 2010; 106: 111-119.
58. Kattman SJ, Witty AD, Gagliardi M, Dubois NC, Niapour M, Hotta A, et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 2011; 8: 228-240.
59. Wamstad JA, Alexander JM, Truty RM, Shrikumar A, Li F, Eilertson KE, et al. Dynamic and coordinated epigenetic regulation of developmental transitions in the cardiac lineage. Cell 2012; 151: 206-220.
60. Suter DM, Molina N, Gatfield D, Schneider K, Schibler U, Naef F. Mammalian genes are transcribed with widely different bursting kinetics. Science 2011; 332: 472-474.
61. Chang HH, Hemberg M, Barahona M, Ingber DE, Huang S. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 2008; 453: 544-547.
62. Belian E, Noseda M, Abreu Paiva MS, Leja T, Sampson R, Schneider MD. Forward programming of cardiac stem cells by homogeneous transduction with MYOCD plus TBX5. PLoS One 2015 June 5, doi:10.1371/journal.pone.0125384.
63. Tateishi K, Ashihara E, Takehara N, Nomura T, Honsho S, Nakagami T, et al. Clonally amplified cardiac stem cells are regulated by Sca-1 signaling for efficient cardiovascular regeneration. J Cell Sci 2007; 120: 1791-1800.
64. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-776.
65. + cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart. PLoS One 2014; 9: e96725, doi:10.1371/journal.pone.0096725.
66. Li TS, Cheng K, Malliaras K, Smith RR, Zhang Y, Sun B, et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 2012; 59: 942-953.
67. +/CD31-cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cells 2006; 24: 1779-1788.
68. Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010; 106: 971-980.
69. Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med 2013; 5: 191-209.
70. Liu ML, Nagai T, Tokunaga M, Iwanaga K, Matsuura K, Takahashi T, et al. Anti-inflammatory peptides from cardiac progenitors ameliorate dysfunction after myocardial infarction. J Am Heart Assoc 2014; 3: e001101, doi:10.1161/JAHA.114.001101.
71. Malliaras K, Ibrahim A, Tseliou E, Liu W, Sun B, Middleton RC, et al. Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction. EMBO Mol Med 2014; 6: 760-777.
72. Kawaguchi N, Smith AJ, Waring CD, Hasan MK, Miyamoto S, Matsuoka R, et al. c-kitpos GATA-4 high rat cardiac stem cells foster adult cardiomyocyte survival through IGF-1 paracrine signalling. PLoS One 2010; 5: e14297, doi:10.1371/journal.pone.0014297.
73. Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu LM, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res 2014; 103: 530-541.
74. Gray WD, French KM, Ghosh-Choudhary SK, Maxwell JT, Brown ME, Platt MO, et al. Identification of therapeutic covariant microRNA clusters in hypoxia treated cardiac progenitor cell exosomes using systems biology. Circ Res 2015; 116: 255-263.
75. Ibrahim AG, Cheng K, Marban E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep 2014; 2: 606-619.
76. Gyongyosi M, Wojakowski W, Lemarchand P, Lunde K, Tendera M, Bartunek J, et al. Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ Res 2015; 116: 1346-1360.
77. Marban E. Breakthroughs in cell therapy for heart disease: Focus on cardiosphere-derived cells. Mayo Clin Proc 2014; 89: 850-858.
78. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, et al. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 2013; 127: 213-223.
79. Avolio E, Meloni M, Spencer HL, Riu F, Katare R, Mangialardi G, et al. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair. Circ Res 2015; 116: e81-e94, doi:10.1161/CIRCRESAHA.1115.306146.
80. Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR, et al. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 2007; 445: 177-182.
81. Chong JJ, Reinecke H, Iwata M, Torok-Storb B, Stempien-Otero A, Murry CE. Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart. Stem Cells Dev 2013; 22: 1932-1943.
82. Wu SM, Fujiwara Y, Cibulsky SM, Clapham DE, Lien CL, Schultheiss TM, et al. Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 2006; 127: 1137-1150.
83. + progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 2006; 127: 1151-1165.
84. Davis DR, Zhang Y, Smith RR, Cheng K, Terrovitis J, Malliaras K, et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 2009; 4: e7195, doi:10.1371/journal.pone.0007195.
85. Chen WC, Baily JE, Corselli M, Diaz ME, Sun B, Xiang G, et al. Human myocardial pericytes: Multipotent mesodermal precursors exhibiting cardiac specificity. Stem Cells 2015; 33: 557-573.
86. Snippert HJ, van der Flier LG, Sato T, van Es JH, van den Born M, Kroon-Veenboer C, et al. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 2010; 143: 134-144.
87. + cells minimally contribute cardiomyocytes to the heart. Nature 2014; 509: 337-341.
88. Nadal-Ginard B, Ellison GM, Torella D. Response to Molkentin’s letter to the editor regarding article, “The absence of evidence is not evidence of absence: The pitfalls of Cre knock-ins in the c-kit locus”. Circ Res 2014; 115: e38-e39, doi:10.1161/CIRCRESAHA.115. 305380.
89. Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrowderived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011; 8: 389-398.
90. Lee YH, Petkova AP, Konkar AA, Granneman JG. Cellular origins of cold-induced brown adipocytes in adult mice. FASEB J 2015; 29: 286-299.
91. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): A prospective, randomised phase 1 trial. Lancet 2012; 379: 895-904.
92. Malliaris K, Makkar RR, Smith RR, Cheng K, Wu E, Bonow RO, et al. Intracoronary cardiosphere-derived cells after myocardial infarction: Evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). J Am Coll Cardiol 2014; 63: 110-122.
93. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram S, et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 2011; 378: 1847-1857.
94. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura J, et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: The SCIPIO trial: Surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012; 126: S54-S64.
95. Ishigami S, Ohtsuki S, Tarui S, Ousaka D, Eitoku T, Kondo M, et al. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: The TICAP prospective phase 1 controlled trial. Circ Res 2015; 116: 653-664.
96. Takehara N, Ogata T, Nakata M, Kami D, Nakamura T, Matoba S, et al. The ALCADIA (Autologous Human Cardiac-Derived Stem Cell To Treat Ischemic Cardiomyopathy) trial [abstract]. Circulation 2012; 126: 2776-2799.